Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2025: EVOLUT Low Risk 5Y Outcomes
Author(s): Michael J Reardon Added: 3 months ago
ACC 2025 - EVOLUT Low-Risk findings show the Medtronic TAVR system is a safe and effective treatment for aortic stenosis vs surgical valves at five years.Dr Michael Reardon (Houston Methodist, Texas, US) joins us onsite at ACC to discuss the EVOLUT Low Risk trial (NCT02701283; Medtronic Cardiovascular), investigating the safety and effectiveness of the Medtronic TAVR system compared to surgical… View more

Intervention
12-months Vessel Healing Profile Following Novel Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Analysis of the BIOMAG-I Trial
Author(s): Added: 1 year ago
In this interview, Dr Masaru Seguchi (German Heart Centre, DE) explains the aim of the BIOMAG-I OCT analysis, what the findings were and what the data means for the future of cardiology. View more

Intervention
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
Author(s): Michael J Reardon Added: 1 year ago
TCT 23 - In this succinct interview, we are joined by Dr Michael Reardon (Houston Methodist, US) to discuss the four-year outcomes from the EVOLUT Low-Risk Trial (NCT03635424), sponsored by Medtronic. The EVOLUT Low-risk trial is a multicenter, prospective, single-arm study which aimed to assess the procedural safety and efficacy of the Medtronic TAVR system in 150 patients with bicuspid… View more

Intervention
TCT 23: 5Y Outcomes From the PARTNER 3 Low-Risk Trial
Author(s): Martin B Leon Added: 1 year ago
TCT 23 - In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year outcomes from Edwards' PARTNER 3 low-risk trial (NCT02675114).PARTNER 3 is a randomized, prospective, multicenter trial that aimed to determine the safety and effectiveness of the SAPIEN 3 transcatheter heart valve in patients with severe calcific aortic… View more

Intervention
Job title: Professor of Vascular Medicine
Martin Lowe
Dr Martin Lowe is a Consultant Cardiologist and Electrophysiologist, specialising in the treatment of arrhythmias in children with catheter ablation and pacemaker / defibrillator implantation.​ His research interests include ablation strategies in those with arrhythmias accompanying cardiomyopathy or congenital heart disease, risk stratification in patients and families predisposed to sudden… View more
Research Area(s) / Expertise:

Prevention & Chronic Conditions

Structural Intervention

Congenital Heart Disease

Inherited and Congenital Cardiac Conditions

Pulmonary Arterial Hypertension

Pregnancy

 Job title: Director, Women Heart Health Programme, Senior Consultant, Department of Cardiology, National University Heart Centre, Singapore
Research Area(s) / Expertise:
EuroPCR 24: The NOTION-2 Study
Author(s): Ole De Backer Added: 1 year ago
EuroPCR 24 - We are joined onsite by Prof Ole De Backer (Rigshospitalet, DK) to discuss the findings from the NOTION-2 Study. (NCT02825134).NOTION-2 is a randomized, multicenter trial which aimed to investigate transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in 376 patients under 75 years of age with severe aortic valve stenosis in regard to intra-… View more

Intervention